Literature DB >> 3521718

Ocular sequelae of preterm birth and their relation to ultrasound evidence of cerebral damage.

J Hungerford, A Stewart, P Hope.   

Abstract

The eyes of 177 very preterm (less than 33 weeks' gestation) infants, born between 1979 and 1982 and admitted to a neonatal intensive care unit, were examined as part of an ongoing follow-up study of neurodevelopmental outcome. Ocular pathology was diagnosed in 37 (21%) of the 177 infants: 14 (8%) had retinopathy of prematurity (ROP)--progressive in three--and nine (5%) infants had delayed visual maturation (DVM). The ocular pathology was permanent in 26 (15%) of the 177 infants. Refractive errors were the commonest problem and accounted for permanent sequelae in eight of the 14 infants with ROP and two of the nine with DVM. The presence or absence of ROP was related to a wide range of prospectively coded perinatal variables and to the results of routine neonatal ultrasound brain scans and neurodevelopmental follow-up assessments made in the first 18 months of life. As in previous studies, infants with ROP were of shorter gestation, lower birth weight, and required oxygen therapy for longer than unaffected infants, but the condition was only weakly associated with other indices of respiratory illness. In contrast, ROP was strongly associated with evidence of brain damage, often consistent with hypoxic ischaemic injury. We conclude that an underlying lesion in ROP may be hypoxic ischaemic damage to the retinal circulation.

Entities:  

Mesh:

Year:  1986        PMID: 3521718      PMCID: PMC1041043          DOI: 10.1136/bjo.70.6.463

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  30 in total

1.  Strabismus and pseudostrabismus with retrolental fibroplasia.

Authors:  R S Foster; H S Metz; A Jampolsky
Journal:  Am J Ophthalmol       Date:  1975-06       Impact factor: 5.258

2.  The possibility of total elimination of retrolental fibroplasia by oxygen restriction.

Authors:  L P GUY; J T LANMAN; J DANCIS
Journal:  Pediatrics       Date:  1956-02       Impact factor: 7.124

3.  [Frequency of ocular changes in premature infants].

Authors:  D E Möller
Journal:  Klin Monbl Augenheilkd       Date:  1970-05       Impact factor: 0.700

4.  The resurgence of retrolental fibroplasia.

Authors:  A S De Leon; J H Elliott; D B Jones
Journal:  Pediatr Clin North Am       Date:  1970-05       Impact factor: 3.278

Review 5.  Outcome for infants of very low birthweight: survey of world literature.

Authors:  A L Stewart; E O Reynolds; A P Lipscomb
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

6.  Effects of changes in systemic blood pressure on the electroretinogram of the cat: evidence for retinal autoregulation.

Authors:  E Demant; K Nagahara; G Niemeyer
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-11       Impact factor: 4.799

7.  Increased morbidity in low-birth-weight survivors with severe retrolental fibroplasia.

Authors:  B R Vohr; C T Coll
Journal:  J Pediatr       Date:  1985-02       Impact factor: 4.406

8.  An association between retinopathy of prematurity and intraventricular hemorrhage in very low birth weight infants.

Authors:  R S Procianoy; J A Garcia-Prats; H M Hittner; J M Adams; A J Rudolph
Journal:  Acta Paediatr Scand       Date:  1981-07

9.  Delayed visual maturation.

Authors:  G F Cole; J Hungerford; R B Jones
Journal:  Arch Dis Child       Date:  1984-02       Impact factor: 3.791

10.  Retrolental fibroplasia--controlled study of 4 years' experience in a neonatal intensive care unit.

Authors:  V Y Yu; D M Hookham; J R Nave
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

View more
  21 in total

1.  Intraventricular haemorrhage and stage 3 retinopathy of prematurity.

Authors:  P Watts; G G Adams; R M Thomas; C Bunce
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Risk factors for strabismus in children born before 32 weeks' gestation.

Authors:  P M Pennefather; M P Clarke; N P Strong; D G Cottrell; J Dutton; W Tin
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

3.  Visual impairment in very low birthweight children.

Authors:  A Powls; N Botting; R W Cooke; G Stephenson; N Marlow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

4.  Cryotherapy and laser treatment for acute retinopathy of prematurity: refractive outcomes, a longitudinal study.

Authors:  F Laws; D Laws; D Clark
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

5.  Ophthalmological morbidity in very-low-birthweight infants with bronchopulmonary dysplasia.

Authors:  O A Ajayi; D Raval; N Lucheese; R S Pildes
Journal:  J Natl Med Assoc       Date:  1997-10       Impact factor: 1.798

6.  Clinical factors associated with retinopathy of prematurity.

Authors:  A Prendiville; W E Schulenburg
Journal:  Arch Dis Child       Date:  1988-05       Impact factor: 3.791

7.  Ocular and visual defects in a geographically defined population of 2-year-old children.

Authors:  M Stayte; A Johnson; C Wortham
Journal:  Br J Ophthalmol       Date:  1990-08       Impact factor: 4.638

8.  Retinopathy of prematurity and brain damage in the very preterm newborn.

Authors:  Elizabeth N Allred; Antonio Capone; Anthony Fraioli; Olaf Dammann; Patrick Droste; Jay Duker; Robert Gise; Karl Kuban; Alan Leviton; T Michael O'Shea; Nigel Paneth; Robert Petersen; Michael Trese; Kathleen Stoessel; Deborah Vanderveen; David K Wallace; Grey Weaver
Journal:  J AAPOS       Date:  2014-06       Impact factor: 1.220

9.  Visual deficits in children born at less than 32 weeks' gestation with and without major ocular pathology and cerebral damage.

Authors:  H J Dowdeswell; A M Slater; J Broomhall; J Tripp
Journal:  Br J Ophthalmol       Date:  1995-05       Impact factor: 4.638

10.  RetCam image analysis of optic disc morphology in premature infants and its relation to ischaemic brain injury.

Authors:  E McLoone; M O'Keefe; V Donoghue; S McLoone; N Horgan; B Lanigan
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.